|
1
|
Izumori K: Bioproduction strategies for
rare hexose sugars. Naturwissenschaften. 89:120–124. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Granström TB, Takata G, Tokuda M and
Izumori K: Izumoring: A novel and complete strategy for
bioproduction of rare sugars. J Biosci Bioeng. 97:89–94. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamaguchi F, Kamitori K, Sanada K, Horii
M, Dong Y, Sui L and Tokuda M: Rare sugar D-allose enhances
anti-tumor effect of 5-fluorouracil on the human hepatocellular
carcinoma cell line HuH-7. J Biosci Bioeng. 106:248–252. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeong RU, Lim S, Kim MO and Moon MH:
Effect of D-allose on prostate cancer cell lines: Phospholipid
profiling by nanoflow liquid chromatography-tandem mass
spectrometry. Anal Bioanal Chem. 401:689–698. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sui L, Dong Y, Watanabe Y, Yamaguchi F,
Hatano N, Izumori K and Tokuda M: Growth inhibitory effect of
D-allose on human ovarian carcinoma cells in vitro. Anticancer Res.
25:2639–2644. 2005.PubMed/NCBI
|
|
6
|
Mitani T, Hoshikawa H, Mori T, Hosokawa T,
Tsukamoto I, Yamaguchi F, Kamitori K, Tokuda M and Mori N: Growth
inhibition of head and neck carcinomas by D-allose. Head Neck.
31:1049–1055. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Indo K, Hoshikawa H, Kamitori K, Yamaguchi
F, Mori T, Tokuda M and Mori N: Effects of D-allose in combination
with docetaxel in human head and neck cancer cells. Int J Oncol.
45:2044–2050. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirata Y, Saito M, Tsukamoto I, Yamaguchi
F, Sui L, Kamitori K, Dong Y, Uehara E, Konishi R, Janjua N, et al:
Analysis of the inhibitory mechanism of D-allose on MOLT-4F
leukemia cell proliferation. J Biosci Bioeng. 107:562–568. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Noguchi C, Kamitori K, Hossain A,
Hoshikawa H, Katagi A, Dong Y, Sui L, Tokuda M and Yamaguchi F:
D-allose inhibits cancer cell growth by reducing GLUT1 expression.
Tohoku J Exp Med. 238:131–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kakolyris S, Giatromanolaki A, Koukourakis
M, Powis G, Souglakos J, Sivridis E, Georgoulias V, Gatter KC and
Harris AL: Thioredoxin expression is associated with lymph node
status and prognosis in early operable non-small cell lung cancer.
Clin Cancer Res. 7:3087–3091. 2001.PubMed/NCBI
|
|
11
|
Nordberg J and Arnér ES: Reactive oxygen
species, antioxidants, and the mammalian thioredoxin system. Free
Radic Biol Med. 31:1287–1312. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ceccarelli J, Delfino L, Zappia E,
Castellani P, Borghi M, Ferrini S, Tosetti F and Rubartelli A: The
redox state of the lung cancer microenvironment depends on the
levels of thioredoxin expressed by tumor cells and affects tumor
progression and response to prooxidants. Int J Cancer.
123:1770–1778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fernandes AP, Capitanio A, Selenius M,
Brodin O, Rundlöf AK and Björnstedt M: Expression profiles of
thioredoxin family proteins in human lung cancer tissue:
Correlation with proliferation and differentiation. Histopathology.
55:313–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Soini Y, Kahlos K, Näpänkangas U,
Kaarteenaho-Wiik R, Säily M, Koistinen P, Pääakkö P, Holmgren A and
Kinnula VL: Widespread expression of thioredoxin and thioredoxin
reductase in non-small cell lung carcinoma. Clin Cancer Res.
7:1750–1757. 2001.PubMed/NCBI
|
|
15
|
Fan J, Yu H, Lv Y and Yin L: Diagnostic
and prognostic value of serum thioredoxin and DJ-1 in non-small
cell lung carcinoma patients. Tumour Biol. 37:1949–1958. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen KS and DeLuca HF: Isolation and
characterization of a novel cDNA from HL-60 cells treated with
1,25-dihydroxyvitamin D-3. Biochim Biophys Acta. 1219:26–32. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishiyama A, Matsui M, Iwata S, Hirota K,
Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y and Yodoi J:
Identification of thioredoxin-binding protein-2/vitamin D(3)
up-regulated protein 1 as a negative regulator of thioredoxin
function and expression. J Biol Chem. 274:21645–21650. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Han SH, Jeon JH, Ju HR, Jung U, Kim KY,
Yoo HS, Lee YH, Song KS, Hwang HM, Na YS, et al: VDUP1 upregulated
by TGF-beta1 and 1,25-dihydroxyvitamin D3 inhibits tumor cell
growth by blocking cell-cycle progression. Oncogene. 22:4035–4046.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH
and Choi I: Tumor suppressor VDUP1 increases p27(kip1) stability by
inhibiting JAB1. Cancer Res. 65:4485–4489. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sheth SS, Bodnar JS, Ghazalpour A,
Thipphavong CK, Tsutsumi S, Tward AD, Demant P, Kodama T, Aburatani
H and Lusis AJ: Hepatocellular carcinoma in Txnip-deficient mice.
Oncogene. 25:3528–3536. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamaguchi F, Takata M, Kamitori K, Nonaka
M, Dong Y, Sui L and Tokuda M: Rare sugar D-allose induces specific
up-regulation of TXNIP and subsequent G1 cell cycle arrest in
hepatocellular carcinoma cells by stabilization of p27kip1. Int J
Oncol. 32:377–385. 2008.PubMed/NCBI
|
|
22
|
Hoshikawa H, Mori T and Mori N: In vitro
and in vivo effects of D-allose: Up-regulation of
thioredoxin-interacting protein in head and neck cancer cells. Ann
Otol Rhinol Laryngol. 119:567–571. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanaji N, Tadokoro A, Susaki K, Yokokura
S, Ohmichi K, Haba R, Watanabe N, Bandoh S, Ishii T, Dobashi H, et
al: Higher susceptibility of NOD/LtSz-scid Il2rg (−/-) NSG mice to
xenotransplanted lung cancer cell lines. Cancer Manag Res.
6:431–436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kanaji N, Nelson A, Allen-Gipson DS, Sato
T, Nakanishi M, Wang X, Li Y, Basma H, Michalski J, Farid M, et al:
The p38 mitogen-activated protein kinases modulate endothelial cell
survival and tissue repair. Inflamm Res. 61:233–244. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alpha-Tocopherol, Beta Carotene Cancer
Prevention Study Group, . The effect of vitamin E and beta carotene
on the incidence of lung cancer and other cancers in male smokers.
N Engl J Med. 330:1029–1035. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lawenda BD, Kelly KM, Ladas EJ, Sagar SM,
Vickers A and Blumberg JB: Should supplemental antioxidant
administration be avoided during chemotherapy and radiation
therapy? J Natl Cancer Inst. 100:773–783. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sayin VI, Ibrahim MX, Larsson E, Nilsson
JA, Lindahl P and Bergo MO: Antioxidants accelerate lung cancer
progression in mice. Sci Transl Med. 6:221ra152014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mochizuki M, Kwon YW, Yodoi J and Masutani
H: Thioredoxin regulates cell cycle via the ERK1/2-cyclin D1
pathway. Antioxid Redox Signal. 11:2957–2971. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wagner JM and Karnitz LM:
Cisplatin-induced DNA damage activates replication checkpoint
signaling components that differentially affect tumor cell
survival. Mol Pharmacol. 76:208–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takahashi Y, Nagata T, Ishii Y, Ikarashi
M, Ishikawa K and Asai S: Up-regulation of vitamin D3 up-regulated
protein 1 gene in response to 5-fluorouracil in colon carcinoma
SW620. Oncol Rep. 9:75–79. 2002.PubMed/NCBI
|
|
31
|
Li Y, Miao LY, Xiao YL, Huang M, Yu M,
Meng K and Cai HR: Hypoxia induced high expression of thioredoxin
interacting protein (TXNIP) in non-small cell lung cancer and its
prognostic effect. Asian Pac J Cancer Prev. 16:2953–2958. 2015.
View Article : Google Scholar : PubMed/NCBI
|
